# Mineralocorticoid Receptor and Obesity Induced Cardiovascular Complications

> **NCT01406015** · NA · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 38 (actual)

## Conditions studied

- Obesity
- Insulin Resistance

## Interventions

- **DRUG:** Spironolactone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01406015
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2013-08
- **Final completion:** 2013-12
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2017-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01406015

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01406015, "Mineralocorticoid Receptor and Obesity Induced Cardiovascular Complications". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01406015. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*